This Powerful Root Destroys Ovarian, Prostate and Colon

New Post Public Reply Private Reply Replies (0) Message Board
wowhappens28
131
This Powerful Root Destroys Ovarian, Prostate and Colon Cancer, and Is STRONGER THAN CHEMOTHERAPY

http://healthadvice365.com/index.php/2017/11/...motherapy/

Unfortunately, most cancer drugs that are currently on the market are not only seriously ineffective at reducing tumors permanently, but actually, cause tumors to become larger and kill the patient more quickly. More specifically, ‘metastasize’ tumors have been found, which means that they become larger and stronger than their original size. According to scientists at the Beth Israel Deaconess Medical Center in Boston, it has been reported that even some of the more expensive drugs are practically the death penalty for many of the patients who consume them.

Unfortunately in recent years, cases of Ovarian, colon, and prostate cancer have increased in the population, for this reason, today we bring you an alternative and very efficient anticancer, which we will present below.

Several studies have yielded a new discovery, which has brought a light to cancer patients and those who wish to prevent it and is nothing more and nothing less than Ginger, which is at our fingertips.

This study revealed that ginger root contains medicinal properties that specifically combat cancer. This was published in the Journal of Chemical and Toxicology indicates that gingerols and paradoxes, (substances contained in ginger), are anticancer components that can help prevent cancer. But the medicinal power of ginger does not get here.

The anti-cancer properties of ginger for women
Ovarian cancer is the most lethal gynecological cancer for women, and one of the most common today. tends to appear as a malignant transformation of the superficial epithelium, and develops as a result of the inflammation produced by ovulation.

Among the anticancer properties of ginger for women, we find gingerol, an anti-inflammatory that can find the cancer cells in the epithelial tissue of the ovary and thus inhibit the growth of them.

It also modulates the secretion of angiogenic factors – creating new blood vessels – into ovarian cancer cells. It is for this reason that ginger to prevent ovarian cancer is an excellent choice now
scientifically studied.

There are a number of new studies that show that ginger can eliminate cancer cells in the ovaries, prostate, and colon and that ginger may be more powerful than chemotherapy as an anti-cancer agent.

Ginger to Destroy Prostate Cancer

According to a study recently published in the British Journal of Nutrition, consuming 100 mg of ginger for every kilogram we weigh works to destroy malignant cells that cause prostate cancer.

The study showed that ginger extract decreased prostate cancer tumors by 56%, while it did not negatively affect healthy cells, so ginger works better than chemo.

Ginger against Cancer of Columbus
In a study published in a Nutrition Review in 2015, researchers showed that ginger not only prevents colon cancer but also removes the cancerous cells that are present in the colon, making ginger a preventative against cancer. chemotherapy and a therapeutic option for those suffering from colorectal cancer worldwide.

The research proved that the use of ginger against cancer did not affect the other cells in the body that need to be divided rapidly, such as cells in the stomach or bones. Ginger does not cause damage to healthy cells makes it a more effective remedy than chemo, since chemo if it causes the death of both cancer cells, but also healthy cells.

Discover your benefits and have a healthier and longer life, with this simple but powerful remedy.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Samuel Oschin Center Opens, Promising Wonder

Updated Category News Views 179

A Grand New Space for Space Well, here's a sight for sore eyes—California Science Center's Samuel Oschin Air and Space Center just swung its doors open wide, and boy, it's a beast of a place. Housing a spectacle like the Space Shuttle Endeavour in a vertical launch position, it's as if they've reached up and snagged a piece of the sky itself for their exhibits. They're...

Continue Reading
Microsoft's Cloud Misstep: Recovery Plans in Focus

Updated Category News Views 133

Microsoft's Stumble Puts CIOs on Alert Thursday's Microsoft 365 outage, a wrench in the works for every firm that ties its daily operations to these cloud services, has brought some harsh truths to the table. On November 12, outages hit users hard, preventing access to Exchange Online mailboxes and sending ripples through Teams, SharePoint, Copilot, and Defender. You...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 171

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 161

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Euroandinos Paita Closes Consent for 2037 Notes

Updated Category News Views 122

Port Strategy and Financial Implications Terminales Portuarios Euroandinos Paita S.A., nestled in the Peruvian transport sector, has been tight-rope walking through its debt landscape. Announcing a successful consent solicitation on November 13, 2026, they've taken a significant step towards reconfiguring their long-term financing game. This puppet show of paperwork...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 175

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
vVARDIS Debuts on NYSE: Transforming Dental Care

Updated Category News Views 92

A New Chapter for Dental Tech Mark your calendars, folks. vVARDIS is stepping onto the New York Stock Exchange (NYSE) stage, waving the banner of NYSE:VVVV. Now, if you've ever sat in that squeaky dental chair feeling the dread of a drill, vVARDIS might just be the new hero in town. Founded by the dynamic duo, Dr. Haley and Dr. Goly Abivardi, they're on a mission to...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 94

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 170

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
Accuray Finishes Key Deal, Resetting Financial Trajectory

Updated Category News Views 136

Accuray Secures the Deal, But Is the Future Bright? Every now and then in the investing world, a company pulls off a maneuver that you wish you’d thought of first. Today, folks, it's Accuray's turn. They've just wrapped up a monstrous transaction with TCW – their primary lender and shareholder – that has them feeling optimistic about the road ahead. Bold Moves to...

Continue Reading

Top 5 Most Recently Viewed Articles

Under Armour and UNLESS: A New Era in Sustainable Sportswear

Updated Category News Views 185

Under Armour and UNLESS Unveil Groundbreaking Sportswear Innovative Launch at Milan Design Week Under Armour, Inc. and UNLESS, Inc. are set to revolutionize the sportswear industry by introducing a remarkable regenerative sportswear collection during Milan Design Week. This innovative project is a significant milestone representing their first collaboration, focusing on...

Continue Reading
Primech Holdings Expands Reach in North America, Targets Growth

Updated Category News Views 111

Primech Holdings Expands Presence in North America Primech Holdings Limited (NASDAQ: PMEC) has marked a significant milestone by opening its United States office in Edwardsville, Illinois. This expansion into North America is driven by the increasing demand for advanced, AI-driven cleaning solutions among institutional clients. Strategic Location for Growth Illinois was...

Continue Reading
Quantum Computing Inc. Secures $500 Million Through Private Placement

Updated Category News Views 296

Quantum Computing Inc. Strengthens Financial Backbone Quantum Computing Inc. (NASDAQ: QUBT), a pioneering company in the realm of integrated photonics and quantum optics technologies, has made headlines with its significant financing move. Recently, QCi announced that it has successfully arranged a private placement of common stock, amassing $500 million. This capital...

Continue Reading
Glaukos Takes Major Step with Epioxa™ FDA Application

Updated Category News Views 80

Glaukos Takes Major Step with Epioxa™ FDA Application Glaukos Corporation (NYSE: GKOS), a distinguished ophthalmic pharmaceutical and medical technology enterprise, has made significant strides by filing a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) for Epioxa™, its state-of-the-art keratoconus therapy. This innovative treatment...

Continue Reading
Freshpet's Upcoming Q1 2025 Results and Company Growth Insights

Updated Category News Views 222

Freshpet to Share First Quarter Results for 2025 Freshpet, Inc. is set to disclose its financial results for the first quarter concluding on March 31, 2025. The announcement is scheduled for the morning of May 5, 2025, just before the market opens. As a public company operating under Nasdaq: FRPT, Freshpet has garnered significant attention in the pet food industry....

Continue Reading